RheumMadness 2025: The Innovation Invitational

Rheum2Learn's Entry #842513
842513
Rheum2Learn
7   View Scoring Rules
34 of 99 (top 34%)
Printable Bracket Printer Friendly Version
Entry Picks
  • The bracket below shows this entry's picks compared to the current results.
  • The correct picks are shown in green and the incorrect picks are shown in red.
Round 2 

CD40L in Sjogren's

BiTEs 

TYK2 in SLE

HCQ Screen Cost

SGCAPS 

Obinutuzumab in LN

Round 3 

BiTEs

TYK2 in SLE

HCQ Screen Cost

Obinutuzumab in LN

Round 4 

BiTEs

Obinutuzumab in LN

Champion 

BiTEs
Comments
The competition was tough. I feel BiTes have the potential to have the biggest impact. CAR-T is impressive but too risky and expensive to have a wide impact. TYK2 but not just for SLE was a close second. And CD40L would be welcome to treat a disease with very few options.
Posted by Rheum2Learn This is my entry. 3/20/2025 2:38:57 PM

Leave a Comment

Login or register to leave a comment.
Correct Picks
Competitor Round Points Earned
CD40L in Sjogren's Round 1 1
TYK2 in SLE Round 1 1
Obinutuzumab in LN Round 1 1
TYK2 in SLE Round 2 2
Obinutuzumab in LN Round 2 2
Incorrect Picks
Competitor Round Points Lost
HCQ Screen Cost Round 1 1
BiTEs Round 2 2
HCQ Screen Cost Round 2 2
BiTEs Round 3 3
Obinutuzumab in LN Round 3 3
BiTEs Round 4 4
Setup your own contest for free at Tourneytopia.com
Server time: 5:50:01 PM Eastern Daylight Time.
Questions? Contact David Leverenz
Please report bugs: support@tourneytopia.com